PATENT CLAIM ANALYSIS

Application Number: 15908218
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "133100"]

Abstract:
Anti-CD122 and/or γc antibodies and fragments thereof are disclosed. Also disclosed are compositions comprising such antibodies and fragments, and uses and methods using the same.

Claim (Index 5):
The antibody or antigen binding fragment according to  claim 1 , which binds to the IL-2R\u03b2/common \u03b3 chain receptor.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 88.0
- Lexical Diversity: 1.4
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15229336', '15750425', '15495048', '15521514', '15521685']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8220519754034546
- 35 USC 102 Novelty (BERT): 0.7127154933465292
- Combined Prediction Score: 0.8111183271977621
- Mean Citation Score: 671.658462
- Max Citation Score: 975.4457
- Similarity Product: 735.2355357312202

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test